Joseph Schlessinger 's Summary
Summary:
In 2008, Dr. Joseph Schlessinger founded Kolltan Pharmaceuticals, Inc, where he currently sits on the Board of Directors and serves as Chairman of the Scientific Advisory Board. Schlessinger also serves as Chairman of the Board at Plexxikon, another pharmaceutical company he established. Possessing over 30 years of scientific research experience, Dr. Joseph Schlessinger has a long history of medical breakthroughs. Dr. Joseph Schlessinger has been behind some of the medical field’s most groundbreaking research, including the discovery of a Raf inhibitor for melanomas, as well as the creation of the first cancer drug for renal cancer and gastrointestinal stromal tumors approved by the FDA. Outside of a research capacity, Dr. Joseph Schlessinger serves as a Professor and Chairman of the Pharmacology Department at the Yale University School of Medicine. As a professor, Dr. Joseph Schlessinger oversees a research group, working closely with graduate students and postdoctoral fellows. Previously, Dr. Schlessinger also served as a Professor at NYU Medical Center as well as his alma mater, The Weizmann Institute of Science in Rehovot, Israel. Possessing a reputation for his extensive knowledge and charismatic public speaking skills, Dr. Joseph Schlessinger is widely sought after for speaking engagements around the world. A talented writer, Dr. Joseph Schlessinger has authored over 400 professional publications. Schlessinger also sits on the editorial boards of industry-specific journals and magazines such as the Journal of Cell Physiology, Growth Factors, Molecular and Cellular Biology, and Cell. Receiving accolades for his professional achievements, Dr. Joseph Schlessinger has won a number of impressive awards, including the Sara Leedy Prize, the Hestrin Prize, the Levinson Prize, the Antoine Lacassagne Prize, and the prestigious Dan David Prize. Joseph Schlessinger also maintains memberships in the National Academy of Science, the American Academy of Arts and Sciences, the National Academy of Sciences Institute of Medicine, the European Academy of Sciences, and the Russian Academy of Sciences.
Specialties:
Pharmaceuticals, Education, Biomedical Research, Scientific Research